Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder
- Sponsor
- Medical University of Vienna
- Study ID
- NCT05577598
- Status
- Recruiting
Conditions
- Obsessive-Compulsive Disorder
- Psychiatric Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Implantation of a DBS therapy system — DEVICEThe system is called "Reclaim DBS Therapy for OCD" und is marketed by Medtronic (Minneapolis, Minnesota). It has a HDE status by the FDA. The system consists of two quadripolar electrodes (Medtronic Reclaim DBS) as well as a generator (Medtronic Activa PC), which will be implanted into a subcutaneous pocket below the clavicula.
Study Details
The purpose of this randomized, sham-controlled study is to evaluate the effectiveness of DBS therapy in individuals suffering from severe OCD and to investigate DBS treatment with functional \[18F\]FDG-Brain-PET.
Key Dates
- First listed
- Oct 13, 2022
- Start date
- Apr 1, 2022
- Status verified
- Jun 2025
- Primary completion
- May 1, 2026
- Completion
- Sep 1, 2026
Study Design
- Enrollment
- 8 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Subjects in this arm will receive active stimulation.The Medtronic DBS system will be implanted in subjects in both study arms. Stimulation will vary depending on the study arm assignment. All subjects will receive therapeutic settings at the end of the blinded period.
- Sham Comparator: Subjects in this arm will receive sham stimulation with DBS being turned off.The Medtronic DBS system will be implanted in subjects in both study arms. Stimulation will vary depending on the study arm assignment. All subjects will receive therapeutic settings at the end of the blinded period.
Primary Outcome Measure
Change of metabolic rates of glucose response pattern [ Time Frame: fPET measurements will take place in Week 4 and Week 5 of the trial. ]
Central Contacts
- Christoph Kraus, MD PhD+43 1 40400 73882
Related Studies
- Locating Biomarkers in OCD Through Behavioral TasksNot Yet Recruiting · Baylor College of Medicine · Pittsburgh, Pennsylvania
- Efficacy of Nitrous Oxide in OCD: Pilot StudyPHASE2 · Recruiting · Stanford University · Stanford, California
- Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum DisordersRecruiting · Stanford University · Stanford, California
- Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCDPHASE1/PHASE2 · Recruiting · Yale University · New Haven, Connecticut